A detailed history of Vestal Point Capital, LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 50,000 shares of TMDX stock, worth $3.77 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
50,000
Holding current value
$3.77 Million
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$59.28 - $144.9 $2.96 Million - $7.25 Million
50,000 New
50,000 $3.12 Billion

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.4B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.